NEW YORK (Reuters) - Former drug executive Martin Shkreli, who last year became a lightning rod for outrage over soaring prescription drug prices, may face additional U.S. charges of securities fraud, a federal prosecutor said on Tuesday.
from Reuters: Top News http://ift.tt/1Tj9gHL
via
IFTTT
No hay comentarios:
Publicar un comentario